ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Cresset Asset Management LLC

Cresset Asset Management LLC lessened its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 84.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,368 shares of the medical instruments supplier's stock after selling 7,227 shares during the period. Cresset Asset Management LLC's holdings in ICU Medical were worth $212,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of ICUI. Harvest Fund Management Co. Ltd purchased a new position in shares of ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP raised its stake in shares of ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp bought a new stake in shares of ICU Medical during the fourth quarter valued at approximately $52,000. Venturi Wealth Management LLC raised its stake in shares of ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its stake in shares of ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after acquiring an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insider Activity

In other ICU Medical news, Director Elisha W. Finney sold 600 shares of the company's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $138.92, for a total value of $83,352.00. Following the sale, the director now directly owns 3,252 shares of the company's stock, valued at approximately $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 5,556 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were sold at an average price of $138.65, for a total transaction of $770,339.40. Following the completion of the sale, the chief operating officer now directly owns 2,389 shares in the company, valued at approximately $331,234.85. The trade was a 69.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 26,167 shares of company stock valued at $3,571,788 over the last ninety days. 1.50% of the stock is currently owned by insiders.

ICU Medical Stock Down 1.3%

NASDAQ ICUI traded down $1.74 on Friday, hitting $128.99. The stock had a trading volume of 149,163 shares, compared to its average volume of 277,478. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -28.23 and a beta of 0.87. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 52-week low of $100.91 and a 52-week high of $196.26. The business's fifty day moving average price is $139.66 and its 200 day moving average price is $152.55.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. The firm had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The business's quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.96 earnings per share. Equities research analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Raymond James decreased their price target on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research note on Friday, May 9th. KeyCorp reduced their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus target price of $192.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.